These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 22897232)
41. A Unique Carboxylic-Acid Hydrogen-Bond Network (CAHBN) Confers Glutaminyl Cyclase Activity on M28 Family Enzymes. Huang KF; Huang JS; Wu ML; Hsieh WL; Hsu KC; Hsu HL; Ko TP; Wang AH J Mol Biol; 2021 Jun; 433(13):166960. PubMed ID: 33774034 [TBL] [Abstract][Full Text] [Related]
42. Discovery of highly potent human glutaminyl cyclase (QC) inhibitors as anti-Alzheimer's agents by the combination of pharmacophore-based and structure-based design. Van Manh N; Hoang VH; Ngo VTH; Ann J; Jang TH; Ha JH; Song JY; Ha HJ; Kim H; Kim YH; Lee J; Lee J Eur J Med Chem; 2021 Dec; 226():113819. PubMed ID: 34536669 [TBL] [Abstract][Full Text] [Related]
43. Glutaminyl cyclase knock-out mice exhibit slight hypothyroidism but no hypogonadism: implications for enzyme function and drug development. Schilling S; Kohlmann S; Bäuscher C; Sedlmeier R; Koch B; Eichentopf R; Becker A; Cynis H; Hoffmann T; Berg S; Freyse EJ; von Hörsten S; Rossner S; Graubner S; Demuth HU J Biol Chem; 2011 Apr; 286(16):14199-208. PubMed ID: 21330373 [TBL] [Abstract][Full Text] [Related]
44. Exploring the binding mode of PQ912 against secretory glutaminyl cyclase through systematic exploitation of conformational ensembles. Chandran R; Dileep KV Chem Biol Drug Des; 2021 Nov; 98(5):850-856. PubMed ID: 34423556 [TBL] [Abstract][Full Text] [Related]
45. Mouse strain and brain region-specific expression of the glutaminyl cyclases QC and isoQC. Höfling C; Indrischek H; Höpcke T; Waniek A; Cynis H; Koch B; Schilling S; Morawski M; Demuth HU; Roßner S; Hartlage-Rübsamen M Int J Dev Neurosci; 2014 Aug; 36():64-73. PubMed ID: 24886834 [TBL] [Abstract][Full Text] [Related]
46. Catalytic implications from the Drosophila protein L-isoaspartyl methyltransferase structure and site-directed mutagenesis. Bennett EJ; Bjerregaard J; Knapp JE; Chavous DA; Friedman AM; Royer WE; O'Connor CM Biochemistry; 2003 Nov; 42(44):12844-53. PubMed ID: 14596598 [TBL] [Abstract][Full Text] [Related]
48. A patent review of glutaminyl cyclase inhibitors (2004-present). Coimbra JRM; Salvador JAR Expert Opin Ther Pat; 2021 Sep; 31(9):809-836. PubMed ID: 33896339 [No Abstract] [Full Text] [Related]
49. Structure and ligand binding of the extended Tudor domain of D. melanogaster Tudor-SN. Friberg A; Corsini L; Mourão A; Sattler M J Mol Biol; 2009 Apr; 387(4):921-34. PubMed ID: 19232356 [TBL] [Abstract][Full Text] [Related]
50. The first potent inhibitors for human glutaminyl cyclase: synthesis and structure-activity relationship. Buchholz M; Heiser U; Schilling S; Niestroj AJ; Zunkel K; Demuth HU J Med Chem; 2006 Jan; 49(2):664-77. PubMed ID: 16420052 [TBL] [Abstract][Full Text] [Related]
51. Increased glutaminyl cyclase activity in brains of Alzheimer's disease individuals. Gunn AP; Wong BX; McLean C; Fowler C; Barnard PJ; Duce JA; Roberts BR; J Neurochem; 2021 Mar; 156(6):979-987. PubMed ID: 32614980 [TBL] [Abstract][Full Text] [Related]
52. The structure of the human glutaminyl cyclase-SEN177 complex indicates routes for developing new potent inhibitors as possible agents for the treatment of neurological disorders. Pozzi C; Di Pisa F; Benvenuti M; Mangani S J Biol Inorg Chem; 2018 Dec; 23(8):1219-1226. PubMed ID: 30132075 [TBL] [Abstract][Full Text] [Related]
53. An alternative mechanism for the catalysis of peptide bond formation by L/F transferase: substrate binding and orientation. Fung AW; Ebhardt HA; Abeysundara H; Moore J; Xu Z; Fahlman RP J Mol Biol; 2011 Jun; 409(4):617-29. PubMed ID: 21530538 [TBL] [Abstract][Full Text] [Related]
55. Discovery of Conformationally Restricted Human Glutaminyl Cyclase Inhibitors as Potent Anti-Alzheimer's Agents by Structure-Based Design. Hoang VH; Ngo VTH; Cui M; Manh NV; Tran PT; Ann J; Ha HJ; Kim H; Choi K; Kim YH; Chang H; Macalino SJY; Lee J; Choi S; Lee J J Med Chem; 2019 Sep; 62(17):8011-8027. PubMed ID: 31411468 [TBL] [Abstract][Full Text] [Related]
56. An overview of glutaminyl cyclase inhibitors for Alzheimer's disease. Coimbra JR; Sobral PJ; Santos AE; Moreira PI; Salvador JA Future Med Chem; 2019 Dec; 11(24):3179-3194. PubMed ID: 31838899 [TBL] [Abstract][Full Text] [Related]
57. The RNA Pol II CTD phosphatase Fcp1 is essential for normal development in Drosophila melanogaster. Tombácz I; Schauer T; Juhász I; Komonyi O; Boros I Gene; 2009 Oct; 446(2):58-67. PubMed ID: 19632310 [TBL] [Abstract][Full Text] [Related]